Recent research indicates that weight loss and diabetes medications, known as glucagon-like peptide-1 receptor agonists (GLP-1), could be beneficial for a range of other health issues. These issues include cardiovascular disease, arthritis, skin conditions, and potentially even cancer prevention.
The use of these drugs is linked to a reduced risk of chronic diseases, with a study from Switzerland suggesting a projected annual mortality rate of 6.4% by 2045.
According to Dr. Sue Dekotis, a certified weight loss physician based in New York City, GLP-1 medications target various health problems throughout the body. She emphasizes, “Nerveogenic diseases like those affecting the heart, kidneys, diabetes, Alzheimer’s, addiction, mental disorders, and autoimmune diseases share common pathways.”
GLP-1 medications, including Semaglutides (Ozempic and Wegovy) and Tirzepatides (Mounjaro and Zepbound), are said to impact multiple body systems. They not only help suppress appetite but also encourage the body to burn fat more effectively.
Experts have noted that fat cells are quite metabolic, producing cytokines that can lead to inflammation, which contributes to various health issues including autoimmune diseases and certain cancers. Dr. Dekotis explains, “By reducing fat cell numbers, we can lower these inflammatory cytokines. That’s part of why we see so many of the positive effects.”
Interestingly, many patients who haven’t lost significant weight still report feeling much better. Doctors have observed an uptick in the use of GLP-1 medications for conditions beyond obesity and diabetes, like rheumatoid arthritis and heart disease.
Dr. Dekotis expresses confidence in prescribing these drugs as a multi-syndrome therapy, citing their safety. “Honestly, I’m more familiar with these treatments than some of the major pharmaceutical options that have emerged over time,” she adds.
For instance, patients with rheumatoid arthritis may find that they lose weight, thus making them suitable candidates for lower doses of GLP-1 medications. Dr. Dekotis notes, “Nine times out of ten, they feel better. It’s incredible how their demeanor changes. Chronic pain can really affect one’s mood and personality; alleviating that can lead to genuine transformations in their lives.”
She advises that those who think they might qualify for GLP-1 treatments should consult certified weight loss physicians to ensure proper prescriptions, thereby avoiding self-medication. “Without knowing your body composition, treatment could be misdirected,” she warns. “While saving a few dollars online may seem tempting, it could lead to regaining weight and wasting time.”
Dr. Dekotis emphasizes the importance of using these medications responsibly, respecting both the treatment and one’s body, and acknowledging that they can be powerful tools when used appropriately.
